ArticleHuman cell2020
MiR-1256 inhibits cell proliferation and cell cycle progression in papillary thyroid cancer by targeting 5-hydroxy tryptamine receptor 3A.
Chaowen Wu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it